Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

15. Employee Benefit Plan

15. Employee Benefit Plan	12 Months Ended
Mar. 31, 2013
Employee Benefit Plan
15. Employee Benefit Plan	NOTE 15 — Employee Benefit Plan The Company has a program to contribute and administer a qualified 401(k) plan. Under the 401(k) plan, the Company matches employee contributions to the plan up to 4% of the employee’s salary. Company contributions to the plans amounted to an aggregate of $140,000 and $103,000 for the years ended March 31, 2013 and 2012, respectively.

15. Employee Benefit Plan

12 Months Ended

Mar. 31, 2013

NOTE 15 — Employee Benefit Plan

The Company has a program to contribute and administer a qualified 401(k) plan. Under the 401(k) plan, the Company matches employee contributions to the plan up to 4% of the employee’s salary. Company contributions to the plans amounted to an aggregate of $140,000 and $103,000 for the years ended March 31, 2013 and 2012, respectively.

- Definition

Tabular disclosure of pension and other postretirement benefit arrangements with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.

+ References + Details